Sanofi

How can we build trust in #healthcare, together? 🤝 At Sanofi, trust is at the heart of everything we do — from our scientific research to our interactions patients, partners, and communities. Trust isn’t just a value we talk about; it’s a standard we work to uphold every day, guided by our Code of Conduct. As the world evolves, so does our Code. We’re updating and including essential areas like human rights, the responsible use of AI, and transparency on social media. Fostering a culture of accountability, openness, and continuous growth is essential to improve people's lives. 👀 Discover our Code of Conduct: http://spkl.io/6046fXtqn

We’re proud to announce the inauguration of our second cutting-edge #Modulus facility, now open in Singapore. This milestone reinforces our commitment to innovation, sustainability, and meeting global healthcare needs with agility and responsibility. Inaugurated by Singapore’s Minister for Health, Mr. Ong Ye Kung, this new facility is a testament to our vision for a sustainable and digitalized future in healthcare. With advanced green technologies like solar power, green electricity, and construction materials made from recycled content, this site showcases our dedication to eco-friendly innovation. As we celebrate this second Modulus facility, we look forward to continuing our mission to bring better health to more people, while paving the way for a sustainable future in healthcare. #WeNeverSettle

When cancer or critical illness touches one of our lives, it impacts all of us. 💙 Our Cancer & Work program offers a 360° global benefit that provides physical, emotional, financial and social support to Sanofians affected by cancer or critical illness, whether they are directly impacted, caregivers or colleagues. What began as a local initiative in France has now grown into a global network with 36 affinity groups, reflecting our commitment to a supportive workplace for all Sanofians. Together, we’re building a compassionate and resilient community. ✨ Learn more: https://lnkd.in/gFi2rm-r

How are we ensuring transparency & explainability in AI?   To produce an output, #AI uses alot of data and complex algorithms. As a result, the process by which AI arrives at an output can be difficult to understand.   To address this issue at Sanofi, we strive to explain the outputs of an AI System when needed.  Read more on how Digital R&D Team integrates explainability into an AI system that predicts factors that increase patient' risk of adverse events during trials: http://spkl.io/6040fXO6i

We’re one step closer to becoming the first biopharma company powered by #AI and now Agents at scale. And that couldn't be possible without our Sanofians. Last week, we held our first global Hackathon on AI agents —The Global Plai Hack Week—uniting 250 top users of our AI decision-making app from France, the USA and China. 💡 The challenge? Design, code, and showcase new AI Agents to unlock our impact and revolutionize our decision intelligence across Sanofi. Meanwhile, over 31,000 Sanofians boosted their skills through a virtual AI masterclass and interactive quizzes. Learn more about our AI journey: http://spkl.io/6043fX8wD #WeNeverSettle #AI AILY LABS #AgentsUnleashed

Missing the #Paris2024 Olympic & Paralympic Games? So are we! 🥹 Relive the magic of the Games with our behind-the-scenes documentary celebrating everything we achieved together through our partnership with Paris 2024. From high-fives to the teary-eyed, this film captures it all through the eyes of Sanofians: our volunteers on their mission, our torchbearers on their journey and the team who planned it, lived it and will never forget it. While the Games may be over for another four years, this journey has ignited our ambition to look beyond what we once thought was impossible. 🎬 Watch the full video here: http://spkl.io/6045fnnJb #WeNeverSettle #IgnitingPotential

The burden of COPD goes beyond just lung function. COPD is a debilitating and devastating disease that often can make it difficult for people to live the life that they want. This #WorldCOPDDay, we join Manuela Buxo in recognizing the resilience of those living with #COPD and reaffirm our commitment to standing with the COPD community and caregivers every step of the way. https://lnkd.in/eEwVyDF8

We’re thrilled to be ranked #3 in the 2024 Access to Medicine Index and recognized as one of the top risers this year! 🌍 This achievement reflects our efforts on access planning for projects in our R&D pipeline and the impactful work of our Global Health Unit. Launched in 2021, our Global Health Unit is driving improved product access in LMICs, fostering partnerships, and championing an inclusive business model recognized as a “Best Practice” in the industry by the Access to Medicine Foundation. Discover how we’re advancing global health 👉 http://spkl.io/6043fVLPN #ATMI24 #AccessToMedicine #HealthcareAccess

Today the FDA accepted the resubmission of our application for an investigational medicine for chronic spontaneous urticaria (CSU), an inflammatory skin disease driven in part by type 2 inflammation. We remain committed to bringing a new option for people suffering from this condition which causes sudden and debilitating hives and recurring itch. Learn more: http://spkl.io/6042fVJ2E Regeneron

The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) recommended the approval of our #MultipleMyeloma combination therapy. If approved, this would be the first therapy in its class available in the EU, in combination with a current standard-of-care regimen, for newly diagnosed multiple myeloma patients who are transplant-ineligible. Read our press release: https://lnkd.in/dnp6T5eM